BGIM
OACCW

Boussard & Gavaudan Investment Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113K Hold
150,000
– – 0.01% 73
2025
Q4 		$133K Hold
150,000
– – 0.01% 83
2025
Q3 		$124K Hold
150,000
– – 0.02% 70
2025
Q2 		$128K Hold
150,000
– – 0.02% 50
2025
Q1 		$114K Buy
+150,000
New +$114K 0.02% 48

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

Boussard & Gavaudan Investment Management's OACCW Position: Q1 2026 in Review

Boussard & Gavaudan Investment Management held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 150,000 shares worth $113K. The position accounts for 0.01% of the portfolio, ranked #73.

Boussard & Gavaudan Investment Management first reported a position in OACCW in Q1 2025 and has held it in 5 quarters since. The position peaked at $133K in Q4 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Boussard & Gavaudan Investment Management held 150,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $113K as of Q1 2026.
  • Boussard & Gavaudan Investment Management left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up 0.01% of Boussard & Gavaudan Investment Management's portfolio in Q1 2026, its #73 holding.
  • Boussard & Gavaudan Investment Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 5 quarters since.
  • Boussard & Gavaudan Investment Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $133K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.